What if a soft material could move on its own, guided not by electronics or motors, but by the kind of rudimentary chemical ...
Dr. Greg Hundley: Yes, Peder, let's go. Dr. Peder Myhre: ...
As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...
This systematic review and meta-analysis found that while yogurt consumption shows a modest positive association with bone ...
Researchers have developed the world’s first flow battery powered by glucose and vitamin B2, mimicking the human body’s ...
(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...
Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with ...
Wellness purchases are now treated more like scientific procurement than regular shopping. Buyers look for data, authenticity ...
Watch parts 1, 2, and 3 of our conversation with Dr Collins.
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today announced that it will present new clinical data from its Phase 2 trial of EB613 at ...
Nanopore sensors enable precise protein and peptide analysis, crucial for early disease diagnosis and advancing personalized healthcare solutions.